DENND2D and hepatocellular carcinoma: Previous studies investigated the function of DENND2D as a tumor-suppressor gene in gastric cancer (GC) [37, 38], lung cancer [39], hepatocellular carcinoma (HCC) [40], and bladder cancer [41].